Guggul (Expanded) for Cholesterol Management

Research suggests that guggul's reputation as a cholesterol-lowering agent is supported by some older randomized controlled trials and mechanistic studies, particularly those conducted in Indian populations, which found reductions in total cholesterol, LDL, and triglycerides, and a 2021 meta-analysis of Ayurvedic herbs also reported favorable findings. However, more rigorous Western RCTs — including a well-cited 2003 trial — found no significant LDL reduction and in one dose group observed an actual increase in LDL, and multiple reviews from 2006 through 2017 have characterized the overall evidence as insufficient or inconsistent. Studies indicate that mechanistic research has identified plausible biological pathways through which guggulsterone may influence cholesterol metabolism, lending some theoretical support to earlier positive findings, but this has not translated reliably into consistent clinical outcomes across populations. The body of evidence is mixed enough that several systematic reviews have concluded the current data do not support a clear LDL-lowering claim, and many researchers have called for larger, better-designed, longer-term trials before firm conclusions can be drawn.